Hormone Therapy
Resource Center
Featured
02/19/2025
Kate Young
Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.
02/19/2025
01/16/2025
Ronald N. Rubin, MD
An otherwise healthy 57-year-old woman presents for further evaluation following an incidental laboratory result discovered on her yearly employment health evaluation.
01/16/2025
12/28/2023
In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...
12/28/2023
Interactive Features
12/06/2019
How well do you know the Endocrine Society's clinical practice guideline for hormonal replacement in hypopituitarism in adults? Test your knowledge in our latest quiz.
12/06/2019
Clinical Insights
12/28/2023
In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...
12/28/2023
11/16/2023
Nanette Santoro, MD
In this video, Nanette Santoro, MD, discusses the efficacy of nonhormonal treatment for patients with vasomotor symptoms (VSM)—also called hot flashes or night sweats—in subgroups of patients considered...
11/16/2023
01/20/2023
In this podcast, Jean Connors, MD, answers our questions about her session at the Anticoagulation Forum 2021, during which she presented about combination oral contraceptives, their use among different...
01/20/2023
08/07/2022
Richard J. Santen, MD, answers questions about his article on the importance of determining the underlying risk of breast cancer for individual patients before initiating menopausal hormone therapy.
08/07/2022
05/19/2022
Caroline Mitchell, MD, reviews the link between the vaginal microbiome and reproductive health, the shift in the vaginal microbial community’s composition after menopause, and more.
05/19/2022
